butylscopolammonium bromide has been researched along with hydroxyzine in 2 studies
Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (hydroxyzine) | Trials (hydroxyzine) | Recent Studies (post-2010) (hydroxyzine) |
---|---|---|---|---|---|
695 | 165 | 149 | 1,489 | 349 | 185 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Arita, K; Natsuga, K; Shimizu, H; Shimizu, T; Tomizawa, K; Ujiie, H | 1 |
2 other study(ies) available for butylscopolammonium bromide and hydroxyzine
Article | Year |
---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
Topics: Adult; Butylscopolammonium Bromide; Drug Therapy, Combination; Exercise; Famotidine; Histamine H1 Antagonists; Histamine H2 Antagonists; Hot Temperature; Humans; Hydroxyzine; Male; Muscarinic Antagonists; Piperazines; Urticaria | 2006 |